Join us for an insightful seminar focused on the discovery and development of complex biologics, including bispecific antibodies (BsAbs) and antibody-drug conjugates (ADCs).

This event brings together leading experts from across the biopharmaceutical industry. Through focused talks and Q&A discussion, we’ll explore key technical challenges, practical solutions, and evolving regulatory expectations shaping the future of advanced therapeutics.